Fondazione Policlinico Universitario Agostino Gemelli - IRCCS
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Schinzari, Giovanni
COMPOSE, NCT04919226 / 2021-001086-20: Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) -

Recruiting
3
250
Europe, US, RoW
177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT, 177Lu-DOTATOC 177Lu-Edo, CAPTEM (Capecitabine and Temozolomide), Amino-Acid Solution, Arginine-Lysine Solution, Everolimus, FOLFOX (Folinic acid + Fluorouracil + Oxaliplatin)
ITM Solucin GmbH
Neuroendocrine Tumors
06/27
09/27
ETNA-FPG, NCT06402695: Observational Study on GEP-and Pulm-NET Treated at FPG

Recruiting
N/A
650
Europe
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Neuroendocrine Tumors, Gep Net, Pulmonary Neuroendocrine Neoplasm
12/25
07/26
Maratta, Maria Grazia
ETNA-FPG, NCT06402695: Observational Study on GEP-and Pulm-NET Treated at FPG

Recruiting
N/A
650
Europe
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Neuroendocrine Tumors, Gep Net, Pulmonary Neuroendocrine Neoplasm
12/25
07/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Schinzari, Giovanni
COMPOSE, NCT04919226 / 2021-001086-20: Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) -

Recruiting
3
250
Europe, US, RoW
177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT, 177Lu-DOTATOC 177Lu-Edo, CAPTEM (Capecitabine and Temozolomide), Amino-Acid Solution, Arginine-Lysine Solution, Everolimus, FOLFOX (Folinic acid + Fluorouracil + Oxaliplatin)
ITM Solucin GmbH
Neuroendocrine Tumors
06/27
09/27
ETNA-FPG, NCT06402695: Observational Study on GEP-and Pulm-NET Treated at FPG

Recruiting
N/A
650
Europe
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Neuroendocrine Tumors, Gep Net, Pulmonary Neuroendocrine Neoplasm
12/25
07/26
Maratta, Maria Grazia
ETNA-FPG, NCT06402695: Observational Study on GEP-and Pulm-NET Treated at FPG

Recruiting
N/A
650
Europe
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Neuroendocrine Tumors, Gep Net, Pulmonary Neuroendocrine Neoplasm
12/25
07/26

Download Options